Compounded tirzepatide week 4 updates: what TikTok gets right and wrong

What did @_hijadetumadre actually say?

At week four on compounded tirzepatide from TryEden, this creator reported zero side effects beyond reduced appetite, described dramatically reduced food noise, and shared a protein coffee routine she credits with helping her hit protein and fiber goals. She's on the lowest available dose and plans to titrate up during week five, which she'll document alongside Pilates content.

Her core claims: she has had "no other" side effects, that "food noise has gone down so much," and that prioritizing protein and fiber is helping her results. She also casually referred to tirzepatide as a "GOP one medication," which is a mispronunciation of GLP-1 but clearly what she meant. None of what she said is reckless. She's not making cure claims or dosing recommendations. She's sharing a personal experience, which is worth evaluating against what the clinical data actually shows.

Does the science back this up?

Mostly, yes. The reduced food noise claim is the most interesting one here, and it has real mechanistic backing. The side-effect report is plausible but incomplete in a way that matters for anyone watching this thinking tirzepatide is a walk in the park.

On food noise: tirzepatide acts on both GLP-1 and GIP receptors, and its effects on appetite go beyond simple stomach emptying. A 2023 paper by Melson et al. in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonism reduces reward-based eating behavior, which maps closely to what people describe as food noise. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) documented appetite reduction as one of the most consistently reported effects across dose groups. So when she says she wakes up and food is "an afterthought," that's pharmacologically coherent.

On protein: the evidence for preserving lean mass during GLP-1-based weight loss with higher protein intake is solid. Cava et al. (2017, Advances in Nutrition) showed that protein intakes above 1.2g per kg of body weight help retain muscle during caloric restriction. Her instinct here is correct.

What did they get wrong (or right)?

She got the food noise description right. She got the protein focus right. What she got incomplete, not necessarily wrong, is the side-effect picture. Reporting zero side effects at week four on the lowest dose of tirzepatide is possible, but it's not the norm, and 72,000 people watching this should know that.

The SURMOUNT-1 trial reported nausea in roughly 30 percent of participants, vomiting in about 10 percent, and diarrhea or constipation as commonly occurring adverse events, particularly during dose escalation. The lowest dose produces fewer GI events than higher doses, so her experience is real and legitimate. But framing it as "no side effects" without that context could leave viewers unprepared for what happens when she titrates up, which she's about to do.

She also called it a "GOP one medication," clearly meaning GLP-1. Minor error, no harm done. What's worth noting for viewers: compounded tirzepatide is not the same product as Zepbound or Mounjaro. FDA has flagged concerns about quality and concentration accuracy in compounded GLP-1 products. That distinction matters and this video doesn't address it at all.

What should you actually know?

If you're considering compounded tirzepatide based on content like this, here's what the creator didn't cover that you need to understand before starting.

• Compounded tirzepatide is not FDA-approved and is not equivalent to brand-name Zepbound. The FDA has issued safety communications about compounded GLP-1 drugs including concerns about dosing errors and sterility. Ask your prescriber directly about sourcing and testing.
• Side effects tend to increase with dose escalation. Week four at the lowest dose is not representative of what weeks eight or twelve might feel like. The SURMOUNT-1 trial showed GI adverse events peaked during titration phases.
• Food noise reduction is real and documented, but individual response varies significantly. Some people experience dramatic effects within weeks. Others see more modest changes. Neither outcome means the medication is or isn't working.
• Protein prioritization during GLP-1 therapy is genuinely evidence-backed. If you're eating significantly less, protecting protein intake helps preserve muscle mass during weight loss.
• Week four results at a starter dose are early data. Weight loss trajectories typically steepen after dose increases. Managing expectations here is not pessimism, it's just reading the trial data.

Bottom line verdict

This is one of the more responsible GLP-1 update videos you'll see on TikTok. She isn't selling anything explicitly beyond a referral hashtag, she's not making medical claims, and her practical advice around protein is grounded. The gap is context. Her side-effect experience is real but not universal, and her compounded product deserves more scrutiny than the video offers. Credit where it's due: the food noise description is accurate and the protein coffee approach is smarter than most "what I eat on Ozempic" content floating around the platform.